Northern Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Northern Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$237K	Buy	+483	New	+$262K	0.17%	98
2025 Q4	–	Sell	-483	Closed	-$234K	–	115
2025 Q3	$234K	Buy	+483	New	+$225K	0.12%	114
2025 Q2	–	Sell	-1,123	Closed	-$559K	–	109
2025 Q1	$559K	Hold	1,123	–	–	0.46%	65
2024 Q4	$584K	Sell	1,123 -245	-18%	-$135K	0.47%	61
2024 Q3	$846K	Sell	1,368 -3	-0.2%	-$1.78K	0.64%	50
2024 Q2	$758K	Sell	1,371 -19	-1%	-$10.9K	0.61%	54
2024 Q1	$808K	Sell	1,390 -17	-1%	-$9.54K	0.63%	56
2023 Q4	$747K	Buy	1,407 +396	+39%	+$192K	0.63%	55
2023 Q3	$512K	Sell	1,011 -736	-42%	-$392K	0.47%	66
2023 Q2	$911K	Buy	1,747 +651	+59%	+$351K	0.8%	38
2023 Q1	$632K	Buy	1,096 +204	+23%	+$115K	0.59%	56
2022 Q4	$491K	Buy	+892	New	+$473K	0.56%	57

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Financial Advisors's TMO Position: Q1 2026 in Review

Northern Financial Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 483 shares worth $237K. The stake represents 0.17% of the portfolio and ranks #98 among its holdings. This is a return to the name: Northern Financial Advisors previously reported a position in TMO as recently as Q3 2025.

Northern Financial Advisors first reported a position in TMO in Q4 2022 and has held it in 12 quarters since. The position peaked at $911K in Q2 2023. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Northern Financial Advisors held 483 shares of Thermo Fisher Scientific worth $237K as of Q1 2026.
Thermo Fisher Scientific was a new Northern Financial Advisors position in Q1 2026.
Thermo Fisher Scientific made up 0.17% of Northern Financial Advisors's portfolio in Q1 2026, its #98 holding.
Northern Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 12 quarters since.
Northern Financial Advisors's Thermo Fisher Scientific position peaked at $911K in Q2 2023.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Northern Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.